Ferring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer

Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.
Le Lézard

Ferring Pharmaceuticals and Theralase® Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer

Ferring Pharmaceuticals and Theralase® Technologies Inc. are pleased to announce that they have entered into a collaborative clinical development agreement ("Agreement") on January 9, 2026. The ...
EuropaWire

AUTOSAR Partnership Announces New Leadership and Core Partners, Strengthening Its Role in the Software-Defined Vehicle Ecosystem

The AUTOSAR partnership is pleased to welcome three longstanding contributors to the AUTOSAR community into the Core Partner circle: DENSO Corporation, Huawei Technologies Co., Ltd, and Vector ...